Trials / Sponsors / CANbridge Life Sciences Ltd.
CANbridge Life Sciences Ltd.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Phase 2 Study of CAN008 in Subjects With GBM Newly-diagnosed Glioblastoma | Phase 2 | 2021-10-10 |
| Unknown | To Evaluate the Efficacy and Safety of CAN008 Combined With Re-irradiation (rRT) for Treating Patients With Re GBM | Phase 2 | 2018-11-20 |
| Unknown | CAN008 Biomarker CD95 Ligand and CpG2 Methylation in Chinese Patients With Glioblastoma Glioblastoma | — | 2017-11-01 |
| Completed | A Study of CAN008 for Newly Diagnosed Glioblastoma Multiforme Glioblastoma Multiforme | Phase 1 | 2016-08-01 |